View in EDS HTML Full Text PDF Full Text

152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL.

Saved in:
Bibliographic Details
Title: 152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL.
Authors: Wu, Jia-Di1 (AUTHOR), Wang, Zhi-Qiang1 (AUTHOR), Zhao, Ze-Rui1 (AUTHOR), Li, Qiao-Qiao1 (AUTHOR), Li, Zhi-Chao1 (AUTHOR), Li, Yu-Hong1 (AUTHOR)
Source: Diseases of the Esophagus. 2023 Supplement, Vol. 36, p1-1. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 171352625
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wu%2C+Jia-Di%22">Wu, Jia-Di</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhi-Qiang%22">Wang, Zhi-Qiang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Ze-Rui%22">Zhao, Ze-Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Qiao-Qiao%22">Li, Qiao-Qiao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhi-Chao%22">Li, Zhi-Chao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yu-Hong%22">Li, Yu-Hong</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Diseases+of+the+Esophagus%22">Diseases of the Esophagus</searchLink>. 2023 Supplement, Vol. 36, p1-1. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=171352625
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/dote/doad052.032
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 1
    Titles:
      – TitleFull: 152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu, Jia-Di
      – PersonEntity:
          Name:
            NameFull: Wang, Zhi-Qiang
      – PersonEntity:
          Name:
            NameFull: Zhao, Ze-Rui
      – PersonEntity:
          Name:
            NameFull: Li, Qiao-Qiao
      – PersonEntity:
          Name:
            NameFull: Li, Zhi-Chao
      – PersonEntity:
          Name:
            NameFull: Li, Yu-Hong
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2023 Supplement
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 11208694
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Diseases of the Esophagus
              Type: main
ResultId 1